The Central Drugs Standard Control Organisation (CDSCO) and Drugs Controller General of India (DCGI) have granted manufacture and marketing licences for anti-covid products to a startup housed at the University of Hyderabad. The firm, MASAA Innovation Private Limited, produced the first anti-Covid and antibacterial medicines in India. It was incubated at ASPIRE BioNEST of UoH.
The items include AMSAA Spray, a disinfectant for cloth, masks, and other surfaces, and SASAA Fog, a fogging liquid and surface cleaning. Adult diapers, wipes, and antimicrobial AMSAA sanitary pads are additional goods. The products are ready to be released in Q1.
The medicines can be used in a variety of settings, including hospitals and laboratories, and are effective against the Covid-19 virus. However, the active ingredient in the goods also acts against a number of other diseases. The products would be introduced to the market very soon in collaboration with independent producers from Gujarat and Telangana.
